Tag Archives: animal testing

Ignorance or Deception?

Animal rights activists may want to start cooling down their engines.

Apparently, by 2050 we can expect the complete elimination of animal use in science.

At least, this is the prediction made by Dr. Andrew Rowan, Chief Scientific Officer of the Humane Society of the United States (HSUS) in a recent article that appeared in The Scientist.

The title of the piece was “Avoiding Animal Testing.  Advances in cell-culture technologies are paving the way to the complete elimination of animals from laboratories”.

The first half of the article focuses on the development and adoption of alternatives to the use of animals in toxicology.  Our public health officials and the FDA have long made the sensible decision to require any company that introduces new chemicals or drugs into the market to provide an initial experimental assessment of their potential toxicity to humans.

This use of animals for such safety screening is typically called animal testing.

Dr. Rowan correctly points out that advances in the development toxicology methods may allow us eventually to relax the regulations that require the use of animals in testing.  But he rapidly moves to insinuate such advances imply that by 2050 we could see the end of animal use in laboratories:

This overall decline in animal use can be attributed to the advent of novel technologies such as improved cell-culture systems and micro-analytic techniques; more sophisticated model systems; improved understanding of signaling and metabolic pathways; and a host of other new methods that allow scientists to answer important questions about the functioning of healthy and diseased tissues without subjecting whole animals to harmful procedures. With a 50 percent decline in animal research since 1975, we are roughly at the halfway point towards the complete elimination of animal research. Thus, we argue that, by 2050, we might finally see the last of animal use in the laboratory, particularly if all stakeholders put their minds to it.

First, the assertion that the total use of animals is systematically declining is not supported by the data.  The slide below, for example, was taken from a recent talk Dr. Rowan gave at the University of Wisconsin.  It shows the total number of animals used has been stable since the mid 80s, with the number of non-genetically modified (Non-GM, faint dashed line) animals decreasing and stabilizing in the 90s (see also data here), while the number of  genetically modified (GM) animals, which are largely mice, has been systematically increasing.

Second, even if correctly asserting that we can expect a diminished need for animals in toxicology testing, Dr. Rowan’s generalization of such trend from a such narrow field to all of biomedical research is groundless and misleading.

Let us be clear, our universities do not engage in animal testing, but in animal research.

What’s the difference?

Scientists are largely concerned with elucidating the basic mechanisms of biological processes in health and disease.  We want to study how cells in our bodies work, how they communicate, how they develop, how they age and how they die.   We want to understand how the brain, our immune system, and internal organs work and how they fail.  And so on…

Why is it critical we develop such an understanding?

Because without this knowledge there will be no hope to combat disease. Indeed, the mission of the National Institutes of Health (NIH) recognizes this fundamental fact in its opening statement,

NIH’s mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life and reduce the burdens of illness and disability.

Implicit in such declaration is the acknowledgment that it is basic knowledge that drives advancements in human health and well-being.  Basic knowledge of nature is what drives progress.  This point is critical –   translational or applied research would not exist without basic knowledge as the raw material.  Without knowledge there would be nothing to translate nor apply.

Those that declare an imminent end to the use of animals in science are effectively implying that they envisage all basic knowledge needed will be acquired by a certain date, or that we will have methods that would allow us to proceed with studies non-invasively in human volunteers. Dr. Rowan’s statement that “Advances in cell-culture technologies are paving the way to the complete elimination of animals from laboratories” is nothing short of utter scientific nonsense.

Is it possible for Dr. Rowan to be ignorant of the role of animals in scientific research?  Could he legitimately be confused about the difference between safety testing on one hand and the development of therapies and basic research on the other?

This seems highly unlikely giving his academic credentials and the fact that he has served on IACUCs before.  In fact, another slide from his talk, shows him delineating these different uses of animals, and illustrating that animal testing for human safety accounts for merely ~25% of total animal use.

No, Dr. Rowan is not confused at all.  He knows what he is talking about.  This is unfortunate as one can only conclude his article is simply a misguided attempt to deceive the public about the fields in which we might realistically expect science to successfully replace animals in the near future.

And I emphasized science above for a good reason.

As difficult as it is for animal advocates to understand, scientists also believe we will see a day when we can eliminate the use of animals in all animal research.  And the day will arrive because of the hard work, progress and achievements of dedicated scientists, such as this one, and not because of deception of those that want to oppose animal research at all cost.

For HSUS to suggest that all animal research could be eliminated by 2050 is  flatly wrong from a scientific point of view, and utterly irresponsible from a public health perspective.

A Closer Look at the Great Ape Protection Act (GAPA)

The status and future of chimpanzee research in the US are at the heart of much discussion lately in both scientific and public spheres.  A committee convened by the Institute of Medicine (IOM) to consider the issue held a number of meetings and is expected to report its findings to the NIH by the end of this year. Legislation to end great ape research, also introduced in 2007 and 2009 (H.R. 1513: Great Ape Protection and Cost Savings Act of 2011;  S. 810: Great Ape  Protection and Cost Savings Act of 2011; GAPA), was again introduced last Spring.

Discussion of human relationships with the great apes, their role in research—past, present, and future—and our responsibility for their continued care deserve thoughtful, well-informed consideration by both the scientific community and the public.  One of the primary goals of Speaking of Research is to contribute to dialogue about animal research and to provide factual information that is sometimes missing from the public conversation.

In the case of chimpanzee research, their housing and care, and the GAPA legislation, it seems clear that there is uneven understanding of the current situation in the U.S., as well as lack of attention to the details and consequences of the proposed legislation were it to be enacted.  There has been significant and widespread discussion of whether chimpanzee research should continue.  What has received far less attention is what should happen to the chimpanzees should invasive research not continue. We take a closer look at GAPA here and also welcome others’ thoughts on the future of chimpanzee research, care, and housing in the U.S..

First up is the question of what exactly would be banned under GAPA.  The legislation is pitched as a measure to end invasive research with chimpanzees.  Much of the media coverage and discussion of chimpanzees in research also makes specific reference to invasive studies.

But what exactly does that mean?  The general definition given by the legislation is:

“The term ‘invasive research’ means any research that may cause death, injury,         pain, distress, fear, or trauma to a great ape, including—

– the testing of any drug or intentional exposure to a substance that may be detrimental to the health or psychological well-being of a great ape;

– research that involves penetrating or cutting the body or removing body parts, restraining, tranquilizing, or anesthetizing a great ape; or

– isolation, social deprivation, or other experimental manipulations that may be detrimental to the health or psychological well-being of a great ape.

Exclusions include:

– close observation of natural or voluntary behavior of a great ape, if the research does not require an anesthetic or sedation event to collect data or record observations;

– the temporary separation of a great ape from the social group of the great ape, leaving and returning by the own volition of the great ape;

– post-mortem examination of a great ape that was not killed for the purpose of examination or research; and the administration of a physical exam by a licensed veterinarian or physician conducted for the well-being of the individual great ape.

Physical Exam is defined as:

A physical exam conducted for the well-being of an individual great ape, as described in clause14 (i)(IV), may include the collection of biological samples to further the well-being of the individual great ape, the social group of the great ape, or the great ape species.”

It seems likely that when most people think of invasive research with chimpanzees they would probably consider studies that involve surgery or infectious disease.  Looking at the text above, it appears obvious that these would be precluded under GAPA.

What is less clear is whether noninvasive studies would also be disallowed under GAPA. Why?

First, because it precludes “research that involves … anesthetizing a great ape” something that is typically necessary to ensure both human and animal safety for studies that use noninvasive techniques such as neuroimaging (ex. magnetic resonance imaging, MRI; positron emission tomography, PET). Studies using MRI and PET with nonhuman primates are aimed at a wide spectrum of research addressing questions that range from evolutionary consideration of brain-behavior relationships to uncovering the effects of aging and factors that contribute to individual differences in health. Are these the types of studies—using equipment and techniques that are commonly used with humans– that typically come to mind as invasive studies? Probably not.

Whether anesthetizing a chimpanzee is an invasive procedure or one that is stressful is not clear-cut and is a question likely to generate a wide range of views among those with first-hand chimpanzee experience.  In part, it depends upon whether animals are trained to voluntarily, calmly, and cooperatively receive injections—something that is a best practice successfully implemented at many chimpanzee research facilities.  This video, shared with us by Dr. Steven Schapiro and the Michael E. Keeling Center for Comparative Medicine and Research  serves as an excellent illustration of the practice.

The video shows a chimpanzee voluntarily, and without coercion, working with his human caregivers to give a sample of blood in exactly the manner of a human blood donor. The chimpanzees shown here are part of a training program led by a long-time leading expert in behavior and primatology, Dr. Schapiro. The video shows a chimpanzee who voluntarily places and holds his arm in a tube to provide a technician with access to draw blood. The chimpanzee is not restrained and is not coerced. The technician cues the chimpanzee with a “clicker” which provides an audible cue to signal the animal. The chimpanzee remains calm throughout the process and receives treats. The curious and calm approach and observation by another chimpanzee also tells us that the entire process is one that is not stressful to the animals.

Much of the language surrounding GAPA appears to be designed to convey a very different impression of the care of chimpanzees housed in research settings. We believe that a more honest discussion of chimpanzees in research should include consideration of the full range of housing and behavioral management, including acknowledgement of best practices such as those illustrated in this video and practiced in a wide range of settings.

The second question about what GAPA would preclude surrounds behavioral and cognitive research.  Many of these studies depend upon testing animals individually by temporarily separating them from their groups. GAPA asserts that such studies would be allowed only under very stringent—and possibly impractical—conditions. The chimpanzee could be temporarily separated from his/her group, but only if it were able to leave and return by its own volition.

For example, consider a recent study of prosocial behavior in chimpanzees by Frans de Waal and colleagues that was published in the Proceedings of the National Academy of Sciences USA.  This study was positively featured on a Scientific American blog that also endorses GAPA. The study was conducted by bringing pairs of animals into a testing room containing tokens that they could exchange with the experimenter for a food reward. Their choices could result in both animals receiving food, or in a “selfish” outcome. The methods section doesn’t specify whether the animals were free to leave and enter the test room at their own volition, but it appears that they were not. If not, would we consider it invasive research?

A third question is whether GAPA would preclude studies that depend upon collection of biological samples that are acquired while animals are anesthetized for physical exams.  The language surrounding this is somewhat ambiguous, as it allows the sample collection if it is to “further the well-being of the individual great ape, the social group of the great ape, or the great ape species.”  What is not ambiguous is that, as written, GAPA would preclude even a simple blood draw—something humans routinely receive as part of medical care or even research—outside of an annual physical exam.

In sum, the issue of defining invasive research and the parameters of what should be allowed is clearly a complex issue. That complexity should be acknowledged in discussions of the future of chimpanzee research.  Virtually all of the procedures used in biomedical research involving chimpanzees that are regarded as invasive procedures are used in human beings in providing medical care.  The GAPA regards these procedures as acceptable if performed for the benefit of the individual great ape to provide care to that animal, but it is unacceptable if it is performed to gain knowledge that will improve the care of human beings or other great apes.

Similarly challenging are a range of other issues presented by consideration of the future of chimpanzees in the U.S., including decisions about their housing and care, as well as the source of long-term funding.

One premise of GAPA is that “research laboratory environments involving invasive research cannot meet the complex physical, social, and psychological needs of great apes.”  Sanctuaries are offered as the alternative for housing, yet little of the public discussion has focused on rigorous comparison of sanctuaries and research facilities in terms of either care offered or cost.

Finally, in this year’s iteration, the legislation has added language about “cost-savings” that appears to be based in analysis provided by the Humane Society of the United States (HSUS).  Whether the cost-savings claim is accurate or not remains open for debate.  Each of these issues will be covered in more detail in subsequent posts.

Whether the current legislation about great ape research passes or not, at this time it is perhaps more apparent than ever before that public interest in discussing the welfare of these animals is high. We hope that this interest carries over to serious discussion about the full range of issues and not only those that lend themselves to short-interest and emotive campaigns.

Allyson J. Bennett

*Disclosure – some of my collaborative research has involved behavioral and neuroimaging studies in laboratory chimpanzees.

YES to Animal Welfare and NO to a Ban on Animal Research

The following is a guest piece by Prof. Michael Hengartner of the Basel Declaration. An organization founded in Germany to promote well-regulated humane research using animals.

The Goals of the Basel Declaration and the Basel Declaration Society

Animal welfare and scientific and medical progress are not contradictory. More than 800 international researchers have already shown their commitment to accepting greater responsibility in animal experiments by signing the Basel Declaration and supporting the corresponding organization. The Basel Declaration Society aims for a more impartial approach to scientific issues by the general public, and more trusting and reliable cooperation with national and international decision makers.

In November 2010, life science researchers from Switzerland, Germany, Sweden, France and the UK addressed the challenges of animal research and adopted the “Basel Declaration”. This document marks an unprecedented effort by the scientific community to achieve more trust, transparency and communication around animal research. The event was echoed in international media, among them the Scientific American, the Medical Tribune and nature.

“The high quality of medical care today would not have been achieved without research in animal experiments. It is important to inform society about the major significance of research using animal experiments for the health of humans and animals,”

- Prof. Dr. Burkhard Ludewig, Director of the Medical Research Center, Institute of Immunobiology, Kantonsspital St. Gallen, Switzerland.

Signatories to the Basel Declaration commit to accepting greater responsibility in animal experiments. They also sign up to intensive, unprejudiced dialogue with the general public. This dialogue is factual, and focuses on achieving concrete goals. The signatories additionally demand that animal experiments needed to obtain research results remain permitted, now and in the future.

“The Basel Declaration came about not in response to any specific occasion, but as a spontaneous voluntary commit­ment by the scientific community to the best-possible approach to indispensable animal experiments. We present a picture of our modern animal experiment-based science, the deliberation process, the basic conditions and our approach to the issue of animal experiments and show openly what we do and why,”

- Prof. Dr. Stefan Treue, Director, German Primate Center, Göttingen, Germany.

The goal is to make the Basel Declaration the worldwide ethical guideline on animal research, comparable to the Helsinki Declaration which defines ethical guidance on research into humans.

“Basically we have long regarded the principles behind the Basel Declaration as a matter of course, because no researcher performs animal experiments unnecessarily. The Basel Declaration establishes a platform for us on which we can network internationally in order to demonstrate this to the public more clearly still. The message is evidently getting across: For the first time we are now engaged in sustained dialogue with representatives of critical organizations in a spirit of genuine partnership that bring all sides together more than any extremist slogans do,”

- Prof. Dr. Rolf Zeller, Department of Biomedicine at the University of Basel, Switzerland and first President of the Basel Declaration Society, which was founded in September 2011.

The Basel Declaration Society celebrates its first birthday

Sign the Basel Declaration!

“The aim is for as many researchers as possible to learn of our initiative and affiliate themselves with it. We invite all colleagues and the general public to accept this offer of a genuine dialogue and to really live this Basel Declaration,”

- Prof. Dr. Michael Hengartner, Dean of the Faculty of Mathematics and Natural Sciences, Institute of Molecular Biology, University of Zurich, Switzerland.

Everybody involved in animal research or animal care around the world is asked to sign the Basel Declaration, and to become a member of the Basel Declaration Society. Doing so marks a commitment to strengthen public awareness of the importance of animal models in experimental biomedical research, to foster communication between researchers and the public, and to enhance acceptance of the Basel Declaration.

Animal research is under ever-increasing public and governmental scrutiny, even though its importance for biomedical innovation and the necessity of animal experiments to further knowledge in basic research are beyond controversy.

Scientists and technical staff conducting animal experiments face increasing public distrust, and often even aggressive rejection. Media covering the topic frequently lack objectiveness.

This is why already more than 800 international leading scientists have signed the Basel Declaration, to show their conviction that responsible animal research and the sustainable advancement of science and medical progress are compatible.

We hope you will join them with your signature.

Better education

“Animal experiments will remain necessary in biomedical research for the foreseeable future, but we are constantly working to refine the methods with animal welfare in mind,”

- Prof. Dr. Michael Hengartner, Dean of the Faculty of Mathematics and Natural Sciences, Institute of Molecular Biology, University of Zurich, Switzerland.

Advancing the knowledge, implementation and use of 3R principles to reduce, replace and refine animal experiments plays an important role in embedding the Basel Declaration in daily practice. All stakeholders, i.e. everyone engaged in experimental research, the general public and authorities/decision takers, must be made more aware of 3R principles and their current implementation. Moreover, 3R-related issues must be an integral part of scientific publications, and peer reviewers must be better informed about the use, dissemination and quality control of 3R methods. More research is required that captures results in a comprehensive and validated database related to 3R technology and methods.

The 3R principle (replace, reduce, refine) has its origins with William M. S. Russell & Rex L. Burch, who published their “Principles of Humane Experimental Technique” in 1959. These principles are regarded internationally as the guideline for avoiding or reducing animal experiments and the suffering of laboratory animals:

  • Replacement: replacement of animal experiments by methods that do not involve animals
  • Reduction: reduction in the number of animals in unavoidable animal experiments
  • Refinement: improvement in experimental procedures, so that unavoidable animal experiments

More than a piece of paper

On October 16-18, 2011, more than 80 international life sciences researchers and signatories to the Basel Declaration met in Berlin. Their aim was to continue making a constructive and active contribution to the debate taking place in society. They request that the incorporation of the new EU Directive on the protection of animals used for scientific purposes into national law by January 2013 happens consistently in all European countries, and to the highest standards – like those in Switzerland.

Animal Welfare is a high priority for scientists

The Swiss severity classification system helps to identify the impact of scientific procedures on the health and well-being of experimental animals. A thorough severity degree classification is essential for improvement in line with the 3R principles. It helps to define humane endpoints in advance, and to assess progress in refinement, project by project. Participants in the Berlin conference recommend the implementation of severity classification systems, and voluntary use of such systems by the scientific community in countries where these are not yet mandatory.

Obligation to the public

Berlin conference delegates unanimously agreed that science must not only take a clear stand on the responsible handling of laboratory animals, but also has to show greater transparency towards the general public. To make their motivation and methods more comprehensible to the public and decision makers, the researchers committed to cooperate more closely with politicians, the media and schools, and to give greater importance to the communication of science. As a first step they presented position papers, developed in working groups, to representatives of the European Parliament, the EU Commission and the Federal Swiss Veterinary Office FVO.

The Basel Declaration signatories acknowledge the need for greater discussion of animal experiment issues and also of the risks of research approaches and possible misuse of new technological developments. In addition, they declare their intention to communicate not only results und scientific controversies, but also processes and approval procedures, in order to foster a deeper understanding of research.

“We realize that society funds our research and has a lot of justified questions on the subject of animal experiments and on research in the life sciences. Our aim is to engage in an in-depth, sustained and transparent dialogue. This reduces anxieties and promotes acceptance of views – on both sides,”

- Prof. Dr. Michael Hengartner, Dean of the Faculty of Mathematics and Natural Sciences, Institute of Molecular Biology, University of Zurich, Switzerland.

Good Lord! They’re Defending Animal Research

Individual European governments are currently working out how to translate a new EU Directive on Animal Research into their own national laws. It would seem a good time for governments to be talking about the benefits of well-funded, humane research using animals. Wait a minute …. the British Parliament are.

To ask Her Majesty’s Government what plans they have to change the regulations governing experiments on animals.

On the 24th October 2011 the British House of Lords (Upper House of Parliament) debated the issue of animal research regulation (click for full text of debate). In response to Lord Wills’ initial questions on the impact of the directive on UK law there was a flood of support for the medical breakthroughs made possible by animal research.

The House of Lords

Lord Winston

Lord (Professor) Winston, an eminent British scientist who works in both reproductive biology and the field of organ transplantation, spoke of the role of animals in experiments in his own field.

My field has largely been that of in vitro fertilisation and reproductive biology. It is interesting to consider that more than 1 million babies could not have existed without the research that has been carried out on rodents. That is true of my work in the screening of embryos for genetic disorders. This has been a revolution in reproductive medicine. It means that women can embark on a pregnancy knowing for certain that they will be free from having a baby which will die in the first few years of life. That was made possible purely through extensive animal research. Animal research has contributed hugely to physiological medical research in virtually every field, whether it be the liver, heart, brain or kidneys, or neuroscience or any major discipline.

Lord Winston also spoke of the need for the Government, and scientific community to engage the public on this issue.

It is quite shocking that every university in this country does not admit that we have an animal house where we do animal experiments. If we do not say this very clearly to the public, if we do not make that message clear, then of course people will start to think there is something clandestine or something to be ashamed of in our research programmes. I really do not think that is true

Baroness Warwick of Undercliffe

Baroness Warwick of Undercliffe, spoke clearly about the benefit of animal research and the high standards of care that exist in the UK.

From my previous experience in the university world, where a substantial proportion of medical research is conducted, I know that the highest standards of ethical behaviour are required and adhered to. That is as true in research involving animals as in other areas. Research using animals has been the fundamental basis for many of the medical advances that we now rely on. I do not think that I can do better than quote the Wellcome Trust, one of the most important funding charities in this field. It said:

“The use of animals in research has enabled major advances in the understanding of biology and led to the development of nearly every type of drug, treatment or surgical procedure in contemporary medical and veterinary practice”.

There is a long list of diseases and treatments where these advances have had an impact-tuberculosis, Parkinson’s disease, high blood pressure, stroke, asthma, Alzheimer’s, and anaesthetics. In the area of organ transplants, in which I have an interest as chair of the Human Tissue Authority, heart and kidney transplant techniques, together with vital anti-rejection medication, were developed using animals-as my noble friend Lord Winston described so vividly. In the financial year 2009-10, 3,706 people received major organ transplants through the NHS.

Using sentient animals in research places a huge responsibility on researchers and Governments. Regulation is therefore essential. Indeed, the UK was the first country in the world to protect research animals by law, in 1876. The UK is now widely regarded as having the tightest legislative control on medical research in the world, together with a reputation for high animal welfare standards. Perhaps even more telling, in order to obtain a license to experiment on animals, researchers must demonstrate to the Home Office that their research cannot be done using alternative non-animal methods.

Lord Taverne, founder of Sense about Science, spoke about the importance of
public support.

Public support is of course important-as many previous speakers have pointed out. The progress made in the three Rs also plays a part in this, and there is no doubt that there has been better education, but it could still be improved. I would add to the suggestion of the noble Lord, Lord Winston, that it would be beneficial if every general practice surgery displayed a notice stating, “All the drugs used or recommended in this surgery have been tested on animals”.

[...]

It is for the sake not only of the health of human beings but of the welfare of animals that we continue to be vigilant to ensure that animal research proceeds effectively and with due care for the animals affected.

Lord Willis of Knaresborough

Lord Willis of Knaresborough, who formerly chaired the House of Commons Science and Technology Committee (as an MP in 2010), gave the Government’s position.

Our priorities are: to promote high-quality science and patient benefits; to ensure high standards of animal welfare; to apply the principles of the three Rs; to harmonise EU regulatory requirements so that we do not have different levels in different countries; and to promote public confidence in humane animal research, which can be done only through openness and transparency. … You cannot achieve world-class research unless you treat your animal models with respect and care.

The British Government continue to affirm their commitment to well regulated biomedical research involving animals. Thank the Lords!

Cheers

Tom Holder

UK Trends in Animal Rights Activism – The Rest of the Story

Recently, I posted an analysis of animal rights extremism in the UK, USA, Italy, Germany, Mexico and Sweden. By looking at the number of Animal rights activities annually over a 3 month period I described in a drop in the number of illegal incidents in the UK.

Incidents of animal rights activism or animal rights extremism

Number of Animal Rights related incidents during the July-Sept period

In the previous post I said:

The UK had the highest levels of activism (average of 24 incidents/quarter) although a massive crackdown on extremism by UK authorities is probably a major part of the decline which has seen only 8 incidents in the July-Sept period for 2010 and 2011 combined. This is certainly promising news for biomedical research in the United Kingdom. See more about activism in Britain in the UK Experience page.

However, an interesting article in The Economist suggested the truth is not quite as positive:


A similar (but not identical) drop in the number of illegal attacks over the time period is shown as in our earlier analysis. However, this is linked by a solid rise in the number of legal protests over the same period. The Economist suggested:

The number of peaceful protests against institutions that perform research on animals has increased markedly of late (see chart), as memories of the violent attacks on the homes and cars of researchers have faded, according to information supplied by members of the Association of the British Pharmaceutical Industry, a lobby group that keeps tabs on such matters. It reckons that many moderate protesters were so appalled at the increasingly abhorrent tactics used by extremists—which culminated in a grave-robbing in 2004—that they abandoned the cause. Only after such attacks had all but halted in 2009 did they return to the barricades.

Organizations such as NETCU – the National Extremism Tactical Coordination Unit – have been effective at curbing animal rights extremism, but were not designed to win the hearts and minds of people to prevent the spread of animal rights ethics. It is crucial that researchers continue to reinforce the link between animal testing and the medical benefits derived from it.

A good example was the recent article in The Independent (UK national newspaper) which explained the crucial need for animal experiments despite the array of other methods that complement such research:

Professor Morris is unapologetic. “There is a lot you can do without animals. Most scientists who use animals do so as part of a whole portfolio of techniques, which will include work with isolated molecules and genes, building up to whole cells growing on plastic dishes in tissue culture to study the more complex integration of cells to work together as a single tissue,” he says. Some 90 per cent of his staff’s work is done with individual molecules and cells in culture.

“At all these stages, extensive use is made of computational modelling, and analyses of databases, to bring together all the information available on how the particular aspect we work on functions in a living body,” he continues. “And there are now non-invasive brain imaging techniques that tell us a lot. But real diseases are diseases of the whole body, and can only be studied in the whole body.”

Dopamine deficiency is a key component of Parkinson’s but the underlying cause is a complex set of interactions triggered by inflammation in the autoimmune system. “So we need to understand the interaction between two complex bodily systems – the brain, and the immune system – to understand this multi-tissue, multi-step disease. The body’s controls on how those two systems interact are lost the moment both are cultured in a plastic dish. We need to look at living brain.”

Cheers

Tom Holder

All in a day’s work: Scientists promote alternatives

Once upon a time, the medication BoTox (made by a company called Allergan) was tested for its potency, on a batch by batch basis, in living animals. This medication, which is really a protein derived from bacteria, has many important therapeutic purposes. For example, it has been shown to be very effective in the treatment of chronic migraine headaches – a condition that can have disabling effects on those who suffer from it. It is used to treat disorders in which people sweat profusely (hyperhidrosis) or have overactive bladders, both of which affect people’s qualities of life by impairing normal social functioning. It has also been used in the treatment of motor disorders like spasticity and dystonia, preventing the irregular and disruptive involuntary movements that are found in these disorders, thereby reducing the physical pain that is so often a consequence of them. Of course, it has also been used for aesthetic reasons, an arguably less compelling medical use.

BoTox is used to treat patients with spastic cerebral palsy, lesseing the pain they suffer as a result of their uncontrolled movements

Because the potency of individual batches of BoTox produced vary, the Food and Drug Administration (FDA) in the United States required Allergan to test each batch on live animals. For each batch, studies were conducted in which the amount of BoTox that was required to produce a specific toxic effect was evaluated in live animals, and the dose was adjusted to ensure that the potency of the drug across batches could be accounted for (roughly, if the batch was half as potent, this can be accounted for by giving twice the dose, ensuring that clinical effects were stable over time). This testing involved a lot of animals, mostly mice.

However, earlier this summer, the FDA changed its mind. It was approached by an organization that had – at considerable expense – developed a test that could determine BoTox potency just as well as the animal tests – but without involving live animals. The test is conducted on cells in a dish.

The organization spent millions of dollars to develop the test and to petition the FDA to consider this replacement for live animal use based upon its empirical results. They were successful.

Who was this organization? Was it the Humane Society of the United States? Perhaps it was People for the Ethical Treatment of Animals, or the Physicians Committee for Responsible Medicine?

It was none of these. Indeed, since none of these organizations spend their operating budgets on the laboratory research that is required to develop alternatives to live animal studies, it couldn’t have been any of them.

So, who accomplished this? It was Allergan itself. Biomedical researchers at the company who used animals in their tests became determined to find a model system that could replace living animals, and they didn’t stop until they found one. They did this though it came at a huge expense to the company. They were committed to producing medicines that people need and to use the fewest animals in the process, and they accomplished that. As the Allergen press release notes, there have been several attempts, using a variety of methods, over the past two decades to develop a replacement for the LD50 test, but until now all these have fallen short.  A report from a 2008 scientific workshop convened by the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)  and the National Toxicology Program Interagency Program for the Evaluation of Alternative Toxicological Methods (NICEATM) provides a good overview of many of the challenges involved in delevoling a replacement for the LD50 test, and the different approaches used to address them.

As always, the alternatives that exist for animal use in biomedical science came from the very scientists who are otherwise roundly criticized by the anti-animal research movement. Maybe the irony is lost on organizations like PCRM, HSUS and PeTA, but not on us. At UCLA, our administration has instituted a funding program that provides seed funding to scientists to promote work on refinement, reduction and replacement. What have the leading anti-research groups done? Nothing, but complain. Perhaps instead of criticizing scientists, these organizations should join with us in attempting to discover alternatives and reduce animal use.

Regards,

David Jentsch

Confronting AR Accusations at a Local and National Level

Charities are regularly targeted by animal rights groups. Currently Animal Aid have been targeting some of the UKs biggest medical research charities including the British Heart Foundation (strong proponents of animal-based research), Cancer Research UK, Alzheimer’s Society and Parkinson’s UK. It was refreshing to see these charities responding to this national press by providing comments about the importance of animal research to their work (see also previous post on this):

Cancer Research UK – “We have strict ethical policies in relation to animals and follow rigorous government guidelines to ensure that animals are only used where there’s no alternative. Millions of people are alive thanks to life-saving treatments for cancer.”
British Heart Foundation – “Research funded by the BHF advances our understanding of the heart and circulatory system in order to improve our ability to prevent, diagnose, monitor and treat cardiovascular disease – saving and improving the lives of those people affected.”
Alzheimer’s Society – “Our research aims to move us closer to a cure and improve the quality of life of people with dementia. We strive to ensure that alternatives are used where possible, that the minimum number of animals are used and that researchers keep to the highest welfare standards.”
Parkinson’s UK – “Experiments involving accurate animal models of Parkinson’s are the key to improved drug screening and swifter movement into clinical trials involving humans for the best drugs that will allow people with Parkinson’s to lead a normal life, free from its symptoms.”

Nonetheless, many charities shy away from dealing with local press accusations, worrying that they may attract more attention, or simply that ignoring them will make the problem go away. So when Animal Aid made a verbal attack on Parkinson’s UK in a local Derby newspaper, it was a nice change to see the organisation respond with an equal measure of vigour.

IN her letter “Campaign seeks an end to research on animals” (Derby Telegraph, September 9) Dawn Spencer, of Animal Aid, makes a number of claims that cannot pass unchallenged.

Ms Spencer claimed that Parkinson’s UK does not wish people to find out how much we spend on research involving animals. I am happy to be open about this. Some 40% of the £4.6m we spend on research each year is on projects involving animals.

Our research work is governed by some of the toughest restrictions in the world, enforced by the Home Office. Details of our UK-funded research are on our website and the research strategy which specifies the development of new models is publicly available. Our policy is also on our website.

Ms Spencer said that “people wanted… alternative research using tissue cells”. We fund the Parkinson’s UK Brain Bank, which supplies donated human brain tissue for Parkinson’s research. However, the use of human tissue is not appropriate in every case.

She comments that “animal experiments can be unreliable and… misleading”. We know that research involving animals has been demonstrated to help to identify improved treatments, help us gain a greater understanding of the causes of the Parkinson’s and ultimately lead to the development of a cure.

Since the 1970s, the lives of millions of people with Parkinson’s have been transformed by taking the drug levodopa, which would not have been developed without the insights gained from research involving animals.

People who give money to Parkinson’s UK can choose to support other areas as we also fund campaigning and support to improve life for everyone affected by Parkinson’s. We’ll keep doing that until we find a cure.

Dr Kieran Breen
Director of research and innovation
Parkinson’s UK

Well done Dr. Breen for this clear and concise reply to Animal Aid.

For those charities considering speaking up in defence of life-saving medical research using animals, I recommend the follwing resources:

1. Understanding Animal Research – A Researchers’ Guide to Communication
2. Association of Medical Research Charities – Medical Research Charities and Animal Studies
3. Understanding Animal Research – Funding Animal Research: Communications Guidelines for Charities

There is no excuse for standing on the sidelines – it is time everyone stood up and spoke of the importance of animal testing.

Cheers

Tom

Speaking of Statistics

We recently updated the statistics page of the website. Here are the highlights:

  • The numbers of dogs used in research was at its lowest rate since measurements began in the 1970s. The current figure is less than 1/3 of its number in the late 1970s.
  • The number of cats used remains at a general low (up very slightly from its historic low in 2009). The figure of 21, 578 is considerably smaller than the 74, 259 used in 1974.
  • Primate research has risen slightly over the past decade, in part due to increasing amounts of research into neurodegerative diseases such as Alzheimer’s, which is expected to affect four times the number people in 2050 as it does today.
  • Cats, dogs and primates together account for around 0.60% of animals used in research, making 2010 the fourth year this percentage has fallen.

The number of animals covered by the Animal Welfare Act used in medical research since 1973. This graph does not include the use of mice or rats.

Check out the statistics page now for more information